Navigation Links
Safeway Raises Over $9 Million to Fund Prostate Cancer Research

PLEASANTON, Calif., July 25, 2012 /PRNewswire/ -- Safeway Inc. (NYSE: SWY) today announced that its month-long Prostate Cancer Awareness Campaign raised over $9 million to help find new treatments and an ultimate cure for prostate cancer.

"We are infinitely grateful for all of the customer and community support for a campaign that will help save the lives of countless men worldwide," said Larree Renda, Safeway Executive Vice President and Chair of the Safeway Foundation. "Prostate cancer is the number one cancer killer of men. These contributions, one dollar at a time, are sparing lives by funding critical research and the absolute best treatment at the most renowned cancer centers in North America."

This is the 12th year that Safeway, one of the largest corporate supporters of cancer research, has dedicated the entire month of June to raising funds at its stores, production facilities and corporate offices for prostate cancer research. The company works with the Prostate Cancer Foundation to identify and provide grants for promising research. The outcomes of the nearly 1,600 Safeway-funded research projects include the identification of more than 27 cancer-causing gene fusions, new biomarkers for diagnosis and treatment response assessment and the development of new drugs to deliver more effective treatments for patients with advanced stages of the disease. The death rate has dropped roughly 40 percent in the U.S. alone, meaning nearly 200,000 American men are alive today because of improved treatment.

"The partnership with Safeway, its customers and employees has been nothing short of amazing," said Jonathan Simons, MD, President and CEO of the Prostate Cancer Foundation. "Advancements made possible by these donations are paving the way for better methods to diagnose and treat patients battling the disease."

The 2012 Prostate Cancer Awareness Campaign included a special promotion through a partnership with Stand Up 2 Cancer — a program of the Entertainment Industry Foundation.  Actress Angie Harmon, star of TNT's original drama series, Rizzoli & Isles, appeared in public service ads (PSA's) supporting cancer research. The PSA's highlighted a limited-edition, reusable shopping bag, embossed with the words, "It starts with a wish; it can end with a cure." The bag was available for purchase at all Safeway locations in the U.S as well as online at

Along with prostate cancer research and support for those with disabilities, Safeway is one of the largest corporate supporters of breast cancer research. In addition, Safeway is an industry leader in environmental sustainability, ethical business practices and effective community outreach.  Safeway upholds an operating philosophy that is rooted in corporate social responsibility focused on four key fundamentals: People, Products, Community, and the Planet.  These fundamentals are "The Heart of Safeway," bringing together our passion for food and serving our customers with the rapidly developing needs of our communities and our planet. In 2011, the company raised and donated more than $180 million for hunger relief, education and the previously mentioned important causes.

Safeway Inc. is a Fortune 100 company and one of the largest food and drug retailers in North America, based on sales. The company operates 1,666 stores in the United States and western Canada and had annual sales of $43.6 billion in 2011. The company's common stock is traded on the New York Stock Exchange under the symbol SWY.

Contact: Teena Massingill, 925-467-3810,

SOURCE Safeway Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
2. Juventas Therapeutics Raises $22.2 Million Series B Financing
3. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
4. Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
5. Cerecor Raises $22 Million Series A Financing
6. Biotech Firm Spun Off from Childrens Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment
7. Cowen Healthcare Royalty Partners Raises $1 Billion
8. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
9. Positron Accepts Economic Incentives Offer From The City Of Gary, Indiana For $30 Million Towards 70 MeV Cyclotron Project
10. Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
11. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
Post Your Comments:
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):